4.8 Article

Catalytic Generation of α-CF3 Eno late: Direct Catalytic Asymmetric Mannich-Type Reaction of α-CF3 Amide

Journal

JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
Volume 136, Issue 52, Pages 17958-17961

Publisher

AMER CHEMICAL SOC
DOI: 10.1021/ja511458k

Keywords

-

Funding

  1. JST ACT-C
  2. KAKENHI from JSPS [25713002]
  3. JSPS
  4. Grants-in-Aid for Scientific Research [12F02505, 25713002] Funding Source: KAKEN

Ask authors/readers for more resources

The introduction of the CF3 unit is a common strategy for modifying pharmacokinetic properties and slowing metabolic degradation in medicinal chemistry. A catalytic and enantioselective addition of alpha-CF3 enolates allows for expeditious access to functionalized chiral building blocks with CF3-containing stereogenicity. To date, alpha-CF3 enolates have been a less explored class of nucleophiles because of rapid defluorination. The present study reveals that a designed alpha-CF3 amide enables a direct asymmetric Mannich-type reaction in a cooperative catalytic system.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Chemistry, Multidisciplinary

Human Oxygenase Variants Employing a Single Protein FeII Ligand Are Catalytically Active

Amelia Brasnett, Inga Pfeffer, Lennart Brewitz, Rasheduzzaman Chowdhury, Yu Nakashima, Anthony Tumber, Michael A. McDonough, Christopher J. Schofield

Summary: The study on human AspH variants reveals insights into its catalytic mechanism, with implications for the functional assignment of 2OG oxygenases and the design of non-protein biomimetic catalysts. The crystal structures show the metal-ligation by only a single protein histidine ligand, indicating a unique approach in Fe-II binding compared to the typical triad of residues. Both H725A and H679A AspH variants exhibit substantial catalytic activity, highlighting their potential applications.

ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2021)

Article Multidisciplinary Sciences

Bispecific repurposed medicines targeting the viral and immunological arms of COVID-19

Martin A. Redhead, C. David Owen, Lennart Brewitz, Amelia H. Collette, Petra Lukacik, Claire Strain-Damerell, Sean W. Robinson, Patrick M. Collins, Philipp Schaefer, Mark Swindells, Chris J. Radoux, Iva Navratilova Hopkins, Daren Fearon, Alice Douangamath, Frank von Delft, Tika R. Malla, Laura Vangeel, Thomas Vercruysse, Jan Thibaut, Pieter Leyssen, Tu-Trinh Nguyen, Mitchell Hull, Anthony Tumber, David J. Hallett, Christopher J. Schofield, David I. Stuart, Andrew L. Hopkins, Martin A. Walsh

Summary: Effective agents to treat coronavirus infection are urgently needed to tackle COVID-19 and prepare for future outbreaks. Target identification, such as the main protease (M-pro) and papain-like protease (PLpro), is essential for protecting against future outbreaks. The discovery of non-antiviral therapeutic agents, including SDZ 224015 and Tarloxotinib, provides promising candidates for clinical evaluation in addressing COVID-19.

SCIENTIFIC REPORTS (2021)

Article Chemistry, Medicinal

Mass Spectrometric Assays Reveal Discrepancies in Inhibition Profiles for the SARS-CoV-2 Papain-Like Protease

Lennart Brewitz, Jos J. A. G. Kamps, Petra Lukacik, Claire Strain-Damerell, Yilin Zhao, Anthony Tumber, Tika R. Malla, Allen M. Orville, Martin A. Walsh, Christopher J. Schofield

Summary: This study reports a mass spectrometry-based assay for monitoring the catalysis of SARS-CoV-2 papain-like protease (PLpro). The results show that the potencies of some reported PLpro inhibitors differ substantially from those obtained using fluorescence-based assays. Some M-pro inhibitors also show inhibitory effects on PLpro. The MS-based assay provides a useful tool for validating inhibitor potencies, especially for those operating by non-covalent mechanisms.

CHEMMEDCHEM (2022)

Article Chemistry, Medicinal

Structure-Activity Studies Reveal Scope for Optimisation of Ebselen-Type Inhibition of SARS-CoV-2 Main Protease

Siegfried T. D. Thun-Hohenstein, Timothy F. Suits, Tika R. Malla, Anthony Tumber, Lennart Brewitz, Hani Choudhry, Eidarus Salah, Christopher J. Schofield

Summary: The study suggests that there is room for optimization of sulfur analogues for improved inhibition of M-pro mediated by ebselen/ebselen derivatives, particularly in terms of enhanced selectivity.

CHEMMEDCHEM (2022)

Article Multidisciplinary Sciences

2-Oxoglutarate derivatives can selectively enhance or inhibit the activity of human oxygenases

Yu Nakashima, Lennart Brewitz, Anthony Tumber, Eidarus Salah, Christopher J. Schofield

Summary: This study demonstrates that synthetic and naturally occurring 2OG derivatives can selectively modulate the activities of FIH and AspH, suggesting that these compounds may serve as a basis for developing 2OG oxygenase-targeting probes and drugs.

NATURE COMMUNICATIONS (2021)

Article Biology

Pseudohypoxic HIF pathway activation dysregulates collagen structure-function in human lung fibrosis

Christopher J. Brereton, Liudi Yao, Elizabeth R. Davies, Yilu Zhou, Milica Vukmirovic, Joseph A. Bell, Siyuan Wang, Robert A. Ridley, Lareb S. N. Dean, Orestis G. Andriotis, Franco Conforti, Lennart Brewitz, Soran Mohammed, Timothy Wallis, Ali Tavassoli, Rob M. Ewing, Aiman Alzetani, Benjamin G. Marshall, Sophie Fletcher, Philipp J. Thurner, Aurelie Fabre, Naftali Kaminski, Luca Richeldi, Atul Bhaskar, Christopher J. Schofield, Matthew Loxham, Donna E. Davies, Yihua Wang, Mark G. Jones

Summary: This study provides evidence that the activation of the hypoxia-inducible factor (HIF) pathway is a critical regulator of pathogenetic collagen structure-function in fibrosis. Oxidative stress can drive the activation of pseudohypoxic HIF pathway, which alters collagen nanostructure and increases tissue stiffness.

ELIFE (2022)

Article Chemistry, Medicinal

Penicillin Derivatives Inhibit the SARS-CoV-2 Main Protease by Reaction with Its Nucleophilic Cysteine

Tika R. Malla, Lennart Brewitz, Dorian-Gabriel Muntean, Hiba Aslam, C. David Owen, Eidarus Salah, Anthony Tumber, Petra Lukacik, Claire Strain-Damerell, Halina Mikolajek, Martin A. Walsh, Christopher J. Schofield

Summary: This study describes the synthesis of penicillin derivatives and investigates their mechanism of inhibition on the SARS-CoV-2 main protease (M-pro) through mass spectrometric and crystallographic analyses. The results suggest that beta-lactams have potential as M-pro inhibitors by forming a stable acyl-enzyme complex through their reaction with the nucleophilic cysteine.

JOURNAL OF MEDICINAL CHEMISTRY (2022)

Article Biochemistry & Molecular Biology

Combined proteomic and biochemical analyses redefine the consensus sequence requirement for epidermal growth factor-like domain hydroxylation

Lennart Brewitz, Bruce C. Onisko, Christopher J. Schofield

Summary: This study redefines the consensus sequence requirements for AspH-catalyzed EGFD hydroxylation and expands the range of hydroxylation catalyzed by AspH. The results show that fibulins are substrates for AspH and reveal the important role of AspH in cellular hydroxylation.

JOURNAL OF BIOLOGICAL CHEMISTRY (2022)

Article Biochemistry & Molecular Biology

Natural and synthetic 2-oxoglutarate derivatives are substrates for oncogenic variants of human isocitrate dehydrogenase 1 and 2

Xiao Liu, Raphael Reinbold, Shuang Liu, Ryan A. Herold, Patrick Rabe, Stephanie Duclos, Rahul B. Yadav, Martine I. Abboud, Sandrine Thieffine, Fraser A. Armstrong, Lennart Brewitz, Christopher J. Schofield

Summary: Variants of isocitrate dehydrogenase (IDH)1/2 alter cancer cell metabolism by reducing 2-oxoglutarate (2OG) to hydroxyglutarate. Synthetic derivatives of 2OG can serve as substrates and 2OG-competitive inhibitors for cancer-associated IDH1/2 variants, and some natural product derivatives are even more efficient substrates than 2OG. The study also suggests the potential of using IDH1/2 variants as biocatalysts and highlights the modulation of IDH1/2 variant activity and inhibition through active site binding.

JOURNAL OF BIOLOGICAL CHEMISTRY (2023)

Article Chemistry, Medicinal

Alkyne Derivatives of SARS-CoV-2 Main Protease Inhibitors Including Nirmatrelvir Inhibit by Reacting Covalently with the Nucleophilic Cysteine

Lennart Brewitz, Leo Dumjahn, Yilin Zhao, C. David Owen, Stephen M. Laidlaw, Tika R. Malla, Dung Nguyen, Petra Lukacik, Eidarus Salah, Adam D. Crawshaw, Anna J. Warren, Jose Trincao, Claire Strain-Damerell, Miles W. Carroll, Martin A. Walsh, Christopher J. Schofield

Summary: Nirmatrelvir is a nitrile-bearing small-molecule inhibitor that, in combination with ritonavir, is used to treat infections by severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2). It interrupts the viral life cycle by inhibiting the SARS-CoV-2 main protease (M-pro) which is essential for processing viral polyproteins into functional nonstructural proteins.

JOURNAL OF MEDICINAL CHEMISTRY (2023)

Article Chemistry, Medicinal

5-Substituted Pyridine-2,4-dicarboxylate Derivatives Have Potential for Selective Inhibition of Human Jumonji-C Domain-Containing Protein 5

Lennart Brewitz, Yu Nakashima, Sonia K. Piasecka, Eidarus Salah, Sally C. Fletcher, Anthony Tumber, Thomas P. Corner, Tristan J. Kennedy, Giorgia Fiorini, Armin Thalhammer, Kirsten E. Christensen, Mathew L. Coleman, Christopher J. Schofield

Summary: Jumonji-C domain-containing protein 5 (JMJD5) is an important 2-oxoglutarate-dependent oxygenase that has various functions in development, circadian rhythm, and cancer. This study discovered potent JMJD5 inhibitors, which are 5-aminoalkyl-substituted derivatives of the broad-spectrum 2OG oxygenase inhibitor pyridine-2,4-dicarboxylic acid (2,4-PDCA). Crystallographic analyses showed that these inhibitors bind to JMJD5 in an induced fit manner, with the C5 substituent of 2,4-PDCA binding to the substrate-binding pocket of JMJD5. Cellular studies revealed that these lead compounds displayed similar phenotypes as clinically observed JMJD5 variants with reduced catalytic activity.

JOURNAL OF MEDICINAL CHEMISTRY (2023)

Article Biochemistry & Molecular Biology

Kinetic and inhibition studies on human Jumonji-C (JmjC) domain-containing protein 5

Anthony Tumber, Eidarus Salah, Lennart Brewitz, Thomas P. Corner, Christopher J. Schofield

Summary: Jumonji-C (JmjC) domain-containing protein 5 (JMJD5) is an oxygenase linked to circadian rhythm and cancer biology. Synthetic 2OG derivatives with cyclic carbon backbones are alternative cosubstrates of JMJD5, demonstrating structural similarity to factor inhibiting hypoxia-inducible transcription factor HIF-a (FIH). Broad-spectrum 2OG oxygenase inhibitors are also efficient JMJD5 inhibitors, while clinical inhibitors like roxadustat do not inhibit JMJD5. Solid phase extraction coupled to mass spectrometry assays will facilitate the development of selective JMJD5 inhibitors for cellular studies.

RSC CHEMICAL BIOLOGY (2023)

Article Biochemistry & Molecular Biology

Studies on the selectivity of the SARS-CoV-2 papain-like protease reveal the importance of the P2′ proline of the viral polyprotein

H. T. Henry Chan, Lennart Brewitz, Petra Lukacik, Claire Strain-Damerell, Martin A. Walsh, Christopher J. Schofield, Fernanda Duarte

Summary: This study investigates how SARS-CoV-2 PLpro binds viral polyprotein-derived oligopeptide substrates through molecular dynamics, docking, and quantum mechanics/molecular mechanics calculations. The results show that a proline located at the P2' position promotes catalysis.

RSC CHEMICAL BIOLOGY (2023)

Article Chemistry, Multidisciplinary

Synthesis of 2-oxoglutarate derivatives and their evaluation as cosubstrates and inhibitors of human aspartate/asparagine-β-hydroxylase

Lennart Brewitz, Yu Nakashima, Christopher J. Schofield

Summary: 2-oxoglutarate (2OG) is crucial in biological processes as a cosubstrate for 2OG oxygenases. Aspartate/asparagine-beta-hydroxylase (AspH), a human 2OG oxygenase, is upregulated in hypoxia and serves as a prognostic marker on cancer cells. Studies demonstrate that subtle chemical changes can significantly impact AspH activity.

CHEMICAL SCIENCE (2021)

Article Chemistry, Multidisciplinary

Mass spectrometry reveals potential of β-lactams as SARS-CoV-2 Mpro inhibitors

Tika R. Malla, Anthony Tumber, Tobias John, Lennart Brewitz, Claire Strain-Damerell, C. David Owen, Petra Lukacik, H. T. Henry Chan, Pratheesh Maheswaran, Eidarus Salah, Fernanda Duarte, Haitao Yang, Zihe Rao, Martin A. Walsh, Christopher J. Schofield

Summary: The study presents a high-throughput M-pro assay and identifies beta-lactams, including penicillin esters, as potential inhibitors of M-pro. These findings suggest the potential of acylating agents for M-pro inhibition in anti-viral chemotherapy.

CHEMICAL COMMUNICATIONS (2021)

No Data Available